ClinConnect ClinConnect Logo
Search / Trial NCT06727695

Effect of BioStrength Training on Muscle Strength and Satisfaction in Adults Aged 30-65

Launched by UNIVERSITY OF GRAZ · Dec 5, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Strength Training Muscle Strength Body Composition Customer Satisfaction Bio Strength Technogym Resistance Training Fitness Equipment Handgrip Strength Randomized Controlled Trial

ClinConnect Summary

This clinical trial is studying the effects of a new type of exercise equipment called BioStrength, compared to traditional strength training machines, on muscle strength and overall fitness in adults aged 30 to 65. Over 12 weeks, participants will either use the BioStrength machines or conventional gym equipment to see which one helps improve muscle strength and body composition more effectively. The researchers will measure things like how strong participants are when doing exercises like leg and chest presses, as well as other physical fitness indicators.

To join the study, participants should be healthy adults aged between 30 and 65, with less than six months of experience in strength training. They should be willing to commit to the 12-week program and be able to perform basic strength exercises. However, individuals with certain health conditions, like heart disease or arthritis, or those who are pregnant, won't be eligible to participate. This trial is a great opportunity for those looking to improve their muscle strength and fitness in a structured environment while contributing to valuable research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Age between 30 and 65 years
  • Healthy individuals without significant medical conditions
  • Less than 6 months of prior strength training experience
  • Willing and able to participate in a 12-week training program
  • Capable of performing strength training exercises such as leg press and chest press
  • Able to provide written informed consent
  • Exclusion Criteria:
  • • History of coronary heart disease
  • History of stroke
  • Need for changes in antihypertensive treatment within 3 months prior to study start
  • Arthritis
  • Pregnancy or less than three months postpartum
  • Pain and movement restrictions
  • Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics)
  • Any medical condition preventing participation in planned endurance and strength training

About University Of Graz

The University of Graz, a leading research institution in Austria, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university brings together experts from diverse fields to address pressing health challenges. Its state-of-the-art facilities and dedication to ethical research practices ensure the highest standards of participant safety and scientific integrity. By fostering a dynamic environment for clinical investigation, the University of Graz aims to translate research findings into meaningful healthcare solutions that benefit the wider community.

Locations

Leibnitz, Styria, Austria

Patients applied

0 patients applied

Trial Officials

Martin Atia

Principal Investigator

University of Graz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported